Trelagliptin Succinate
APICAS: 1029877-94-8
Sample Stock:
Trelagliptin Succinate is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting this enzyme to increase the level of incretin hormones in the body, thereby promoting insulin secretion and lowering blood glucose for the treatment of type 2 diabetes. Its most notable feature is an ultra-long duration of action, allowing for once-weekly oral dosing, which significantly enhances patient convenience and medication adherence.
Related Information
Purity:99%+
Registration:GMP/DMF
Biological Profile
Biological Targets
DPP4
Associated Conditions
type 2 diabetes mellitus·diabetes mellitus
Key Intermediates
7 Items| Structure | Name | CAS No. | Sample Stock | MDL No. | Details |
|---|---|---|---|---|---|
 | 4-Fluoro-2-methylbenzonitrile | 147754-12-9 | MFCD03095106 | ||
 | 2-(Bromomethyl)-4-fluorobenzonitrile | 421552-12-7 | MFCD08059542 | ||
 | 2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile | 865759-24-6 | MFCD23695357 | ||
 | (3R)-piperidin-3-amine | 127294-73-9 | MFCD03093369 | ||
 | Methyl (2R)-2,5-diaminopentanoate hydrochloride | 205598-55-6 | MFCD27578365 | ||
 | (R)-3-Aminopiperidin-2-one hydrochloride | 406216-02-2 | MFCD09752974 | ||
 | (R)-2-(Piperidin-3-yl)isoindoline-1,3-dione | 886588-61-0 | MFCD22495246 |